- Home
- WAVE vs BOLD Comparison
WAVE vs BOLD Comparison
Compare WAVE & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- BOLD
- Stock Information
- Founded
- WAVE 2011
- BOLD 2018
- Country
- WAVE Israel
- BOLD United States
- Employees
- WAVE N/A
- BOLD N/A
- Industry
- WAVE Electric Utilities: Central
- BOLD
- Sector
- WAVE Utilities
- BOLD
- Exchange
- WAVE Nasdaq
- BOLD Nasdaq
- Market Cap
- WAVE 51.7M
- BOLD 49.5M
- IPO Year
- WAVE 2021
- BOLD 2024
- Fundamental
- Price
- WAVE $9.22
- BOLD $1.96
- Analyst Decision
- WAVE
- BOLD Buy
- Analyst Count
- WAVE 0
- BOLD 3
- Target Price
- WAVE N/A
- BOLD $22.50
- AVG Volume (30 Days)
- WAVE 32.2K
- BOLD 45.2K
- Earning Date
- WAVE 03-31-2025
- BOLD 04-03-2025
- Dividend Yield
- WAVE N/A
- BOLD N/A
- EPS Growth
- WAVE N/A
- BOLD N/A
- EPS
- WAVE N/A
- BOLD N/A
- Revenue
- WAVE $279,000.00
- BOLD N/A
- Revenue This Year
- WAVE N/A
- BOLD N/A
- Revenue Next Year
- WAVE N/A
- BOLD N/A
- P/E Ratio
- WAVE N/A
- BOLD N/A
- Revenue Growth
- WAVE 933.33
- BOLD N/A
- 52 Week Low
- WAVE $1.01
- BOLD $1.95
- 52 Week High
- WAVE $17.63
- BOLD $15.24
- Technical
- Relative Strength Index (RSI)
- WAVE 50.33
- BOLD N/A
- Support Level
- WAVE $8.26
- BOLD N/A
- Resistance Level
- WAVE $9.00
- BOLD N/A
- Average True Range (ATR)
- WAVE 0.80
- BOLD 0.00
- MACD
- WAVE 0.17
- BOLD 0.00
- Stochastic Oscillator
- WAVE 64.62
- BOLD 0.00
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.